Promoting production in the extracellular matrix without compromising barrier.
Lintner
Karl
K
Sederma, Le-Perray en Yvelines, France.
D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D024042:Collagen Type I / Q000096:biosynthesis*; D005148:Facial Dermatoses / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D010455:Peptides / Q000008:administration & dosage*; D011347:Procollagen / Q000096:biosynthesis*; D015595:Skin Aging
D024042:Collagen Type I; D010455:Peptides; D011347:Procollagen